TrialMuscle & nerve2017

Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability.

James D Berry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.